Metraipolis › archive › dc_6f7532bb8237
Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42367398
- DOI
- 10.7759/cureus.109685
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:51:31.835Z
- SHA-256 of the archived text
18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc- Stable URL of this page
https://metraipolis.com/documento/dc_6f7532bb8237
How to cite
Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398 — Europe PMC (en), https://europepmc.org/article/MED/42367398 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f7532bb8237 (Metraipolis archive dc_6f7532bb8237, sha256 18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc)
BibTeX
@misc{dc6f7532bb8237,
title = {Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete — Europe PMC PMID:42367398},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42367398},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f7532bb8237; sha256 18e4b62f12753472cb32565193f7fb601d8570eaa0ffc49f31b08a7b3aa2bccc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367398. Agents can read the archived copy with the MCP tool read_document.